| Patents for A61K 31 - Medicinal preparations containing organic active ingredients (785,912) |
|---|
| 09/13/2007 | CA2645168A1 Use of light-active indocyanine green for treating inflammatory disorders in the oral cavity |
| 09/13/2007 | CA2645137A1 Heterobicyclic pyrazole compounds and methods of use |
| 09/13/2007 | CA2645110A1 Pharmaceutical composition for external use |
| 09/13/2007 | CA2645095A1 Inhibition of microtubule protrusion in cancer cells |
| 09/13/2007 | CA2645093A1 Use of adenine-derived compounds for the treatment of lupus |
| 09/13/2007 | CA2645086A1 Use of 3,5-seco-4-norcholestane derivatives for obtaining a cytoprotective medicament |
| 09/13/2007 | CA2645072A1 Substituted aminothiazole derivatives with anti-hcv activity |
| 09/13/2007 | CA2645070A1 Pharmaceutical composition for external use |
| 09/13/2007 | CA2645058A1 Pharmaceutical composition for external use |
| 09/13/2007 | CA2645053A1 Immunomodulatory compounds and treatment of diseases related to an overproduction of inflammatory cytokines |
| 09/13/2007 | CA2645031A1 Pyrrolotriazine aniline prodrug compounds useful as kinase inhibitors |
| 09/13/2007 | CA2645018A1 Pharmaceutical combination |
| 09/13/2007 | CA2644996A1 A2a adenosine receptor antagonists |
| 09/13/2007 | CA2644985A1 An improved method of weaning from hormonal treatment of hormone depletion induced vasomotor symptoms |
| 09/13/2007 | CA2644981A1 Pharmaceutical formulation comprising fluoroquinolones |
| 09/13/2007 | CA2644905A1 Ezetimibe compositions |
| 09/13/2007 | CA2644889A1 Compositions and methods for the treatment of immunoinflammatory disorders |
| 09/13/2007 | CA2644850A1 Quinoline and isoquinoline derivatives as phosphodiesterase 10 inhibitors |
| 09/13/2007 | CA2644804A1 A cyclohexane polyalcohol formulation for treatment of disorders of protein aggregation |
| 09/13/2007 | CA2644751A1 Gsk-3 inhibitors for the treatment of osteoporosis |
| 09/13/2007 | CA2644672A1 Quinazoline derivatives as phosphodiesterase 10 inhibitors |
| 09/13/2007 | CA2644661A1 Prodrugs of benzoquinolizine-2-carboxylic acid |
| 09/13/2007 | CA2644613A1 Compositions and methods for treating respiratory disorders |
| 09/13/2007 | CA2644555A1 Nanofluidized b-12 composition and process for treating pernicious anemia |
| 09/13/2007 | CA2644520A1 Thiadiazole compounds and their use in phototherapy |
| 09/13/2007 | CA2644494A1 Processes for synthesizing 7-alkynyl-4-aminoquinazolines and a related intermediate |
| 09/13/2007 | CA2644421A1 Use of vx-702 for treating rheumatoid arthritis |
| 09/13/2007 | CA2644280A1 Phosphodiesterase 10 inhibitors |
| 09/13/2007 | CA2644262A1 Antisense antiviral compound and method for treating arenavirus infection |
| 09/13/2007 | CA2644240A1 Compounds for inhibiting beta-amyloid production |
| 09/13/2007 | CA2644219A1 Method and apparatus for acne treatment using low intensity light therapy |
| 09/13/2007 | CA2644198A1 Pharmaceutical latrunculin formulations |
| 09/13/2007 | CA2644166A1 Use of adenosine a1 and/or dual a1/a2b agonists for production of medicaments for treating diseases |
| 09/13/2007 | CA2644154A1 Stearidonic acid for improving cardiovascular health |
| 09/13/2007 | CA2644118A1 Treatment of atherosclerotic disease |
| 09/13/2007 | CA2644020A1 Prolongation of survival of an allograft by inhibiting complement activity |
| 09/13/2007 | CA2644017A1 Phospholipid complexes of curcumin having improved bioavailability |
| 09/13/2007 | CA2643895A1 Reduction of the titratable acidity and the prevention of tooth and other bone degeneration |
| 09/13/2007 | CA2643796A1 Polycyclic cinnamide derivatives |
| 09/13/2007 | CA2643694A1 Novel heterocyclic cycloalkyl derivatives, method for the preparation thereof, and pharmaceutical compositions containing the same |
| 09/13/2007 | CA2643385A1 Compositions and methods for increasing adipose metabolism, lipolysis or lipolytic metabolism via thermogenesis |
| 09/13/2007 | CA2643363A1 Bicyclic heterocycles, medicaments containing these compounds, their use and process for preparing them |
| 09/13/2007 | CA2643362A1 Use of pyrazolo[1,5a]pyrimidin-7-yl amine derivatives in the treatment of neurological disorders |
| 09/13/2007 | CA2643350A1 Meridamycin analogues for the treatment of neurodegenerative disorders |
| 09/13/2007 | CA2643199A1 Modulation of neurogenesis by nootropic agents |
| 09/13/2007 | CA2642870A1 Improved prodrugs of cc-1065 analogs |
| 09/13/2007 | CA2642859A1 4-amino-1,5-substituted 1,5-dihydro-imidazol-2-ones |
| 09/13/2007 | CA2642744A1 Method and composition for treating chronic obstructive pulmonary disease |
| 09/13/2007 | CA2642602A1 Substituted arylsulfonamides as antiviral agents |
| 09/13/2007 | CA2634133A1 An improved process for the preparation of armodafinil |
| 09/13/2007 | CA2631713A1 Modulators of cdc2-like kinases (clks) and methods of use thereof |
| 09/12/2007 | EP1832663A2 Uses of DNA-PK |
| 09/12/2007 | EP1832657A1 Methylation of plasmid vectors |
| 09/12/2007 | EP1832655A2 Methods for detecting and reversing resistance to macrocyclic lactone compounds |
| 09/12/2007 | EP1832598A2 Therapeutic treatment of androgen receptor driven conditions |
| 09/12/2007 | EP1832592A2 15-C Isomers of rapamycin and of 42-EPI rapamycin, preparation and use thereof |
| 09/12/2007 | EP1832591A1 12-position substituted mutilin derivative |
| 09/12/2007 | EP1832590A2 Tri- heterocyclic compounds and a pharmaceutical comprising them as an active ingredient |
| 09/12/2007 | EP1832589A1 Inhibitors of cyclin-dependent kinases,compositions and uses related thereto |
| 09/12/2007 | EP1832588A1 Condensed imidazole compound and use thereof |
| 09/12/2007 | EP1832586A1 Thiazole-piperidine derivatives in treatment of diseases of liver and the pancreas |
| 09/12/2007 | EP1832585A1 Thiazole-piperidine derivatives for treatment of hyperproliferative diseases |
| 09/12/2007 | EP1832584A1 Pyrimidinylisoxazol derivative |
| 09/12/2007 | EP1832583A1 Novel raloxifene sulphuric acid addition salts and/or solvates thereof, and pharmaceutical compositions comprising these |
| 09/12/2007 | EP1832582A1 Novel raloxifene malonic acid addition salts and/or solvates thereof, and pharmaceutical compositions comprising these |
| 09/12/2007 | EP1832580A1 Crystal and salt of 1-cyclopropylmethyl-4-ý2-(3,3,5,5)-tetramethylcyclohexyl)phenyl¨piperazine |
| 09/12/2007 | EP1832577A1 Improved prodrugs of CC-1065 analogs |
| 09/12/2007 | EP1832576A1 4-Biarylyl-1-phenolyzetidin-2-ones |
| 09/12/2007 | EP1832575A1 Anti-inflammatory agents |
| 09/12/2007 | EP1832302A1 Biodegradable and bioresorbable material for medical use |
| 09/12/2007 | EP1832301A2 Coatings for implantable medical devices |
| 09/12/2007 | EP1832298A1 Matrix-type controlled release preparation comprising basic substance or salt thereof, and process for production of the same |
| 09/12/2007 | EP1832297A1 Anticoagulant agents useful in treatment of thrombosis |
| 09/12/2007 | EP1832293A1 Remedy for cancer metastasis and cancer metastasis inhibitor |
| 09/12/2007 | EP1832292A1 Treatment of neurodegenerative disease through intracranial delivery of short interfering RNA (siRNA) |
| 09/12/2007 | EP1832291A2 use of pyridoxal phosphate for the treatment of diabetes and related complications |
| 09/12/2007 | EP1832290A2 Compositions and methods for use in targeting vascular destruction |
| 09/12/2007 | EP1832289A2 Compositions and coatings for implantable medical devices |
| 09/12/2007 | EP1832288A1 Stable granular pharmaceutical composition of solifenacin or its salt |
| 09/12/2007 | EP1832287A2 The use of anti-histaminics for acute reduction of elevated intracranial pressure |
| 09/12/2007 | EP1832286A1 Preventive or therapeutic agent for sleep disorder |
| 09/12/2007 | EP1832285A1 Formulation comprising fenofibric acid or a physiologically acceptable salt thereof |
| 09/12/2007 | EP1832284A1 Adiponectin inducer or secretagogue |
| 09/12/2007 | EP1832283A1 Use of inhibitors of scavenger receptor class proteins for the treatment of infectious diseases |
| 09/12/2007 | EP1832279A2 A process for the preparation of suspensions of drug particles for inhalation delivery |
| 09/12/2007 | EP1832278A1 Zinc cysteinate for treating inflammations or allergies of the respiratory tracts |
| 09/12/2007 | EP1832181A2 Microbial oil mixtures and uses thereof |
| 09/12/2007 | EP1832179A1 Carbohydrate fraction composition and flat glucose response |
| 09/12/2007 | EP1831683A1 Methods of modulating the activities of alpha7 nicotinic acetylcholine receptor |
| 09/12/2007 | EP1831370A1 Polynucleotides and polypeptide sequences involved in the process of bone remodeling |
| 09/12/2007 | EP1831369A2 Rnai inhibition of serum amyloid a for treatment of glaucoma |
| 09/12/2007 | EP1831367A2 Methods and agents useful in treating conditions characterized by mucus hyperproduction/hypersecretion |
| 09/12/2007 | EP1831240A1 18-methyl-19-nor-17-pregn-4-en-21,17-carbolactones and pharmaceutical preparations comprising the same |
| 09/12/2007 | EP1831235A2 Lung-targeted drugs |
| 09/12/2007 | EP1831231A1 Nicotinic acetylcholine receptor ligands |
| 09/12/2007 | EP1831230A1 Process for obtaining levofloxacin free from salts |
| 09/12/2007 | EP1831229A1 Thienopyrimidine derivatives as phosphodiesterase 10 inhibitors |
| 09/12/2007 | EP1831228A1 Novel pyrazole derivatives and their use as modulators of nicotinic acetylcholine receptors |
| 09/12/2007 | EP1831227A2 Novel heterocyclic compounds useful for the treatment of inflammatory and allergic disorders |
| 09/12/2007 | EP1831226A2 CHIRAL FUSED 1,2 IMIDAZO 4,5-c RING COMPOUNDS |